These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24897986)

  • 21. Polymyalgia rheumatica and temporal arteritis: managing older patients.
    Pereira M; Kaine JL
    Geriatrics; 1986 Jun; 41(6):54-5, 59-60, 63 passim. PubMed ID: 3710167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment and management of polymyalgia rheumatica in older adults.
    Kennedy-Malone LM; Enevold GL
    Geriatr Nurs; 2001; 22(3):152-5; quiz 155. PubMed ID: 11410767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 24-year-old man with symptoms and signs of polymyalgia rheumatica.
    Whittaker PE; Fitzsimons MG
    J Fam Pract; 1998 Jul; 47(1):68-71. PubMed ID: 9673611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis.
    Proven A; Gabriel SE; O'Fallon WM; Hunder GG
    J Rheumatol; 1999 Jun; 26(6):1333-7. PubMed ID: 10381052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition and management of polymyalgia rheumatica and giant cell arteritis.
    Caylor TL; Perkins A
    Am Fam Physician; 2013 Nov; 88(10):676-84. PubMed ID: 24364483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of criteria for polymyalgia rheumatica.
    Bird HA; Esselinckx W; Dixon AS; Mowat AG; Wood PH
    Ann Rheum Dis; 1979 Oct; 38(5):434-9. PubMed ID: 518143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.
    Hutchings A; Hollywood J; Lamping DL; Pease CT; Chakravarty K; Silverman B; Choy EH; Scott DG; Hazleman BL; Bourke B; Gendi N; Dasgupta B
    Arthritis Rheum; 2007 Jun; 57(5):803-9. PubMed ID: 17530680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in polymyalgia rheumatica.
    Owen CE; Buchanan RR; Hoi A
    Intern Med J; 2015 Nov; 45(11):1102-8. PubMed ID: 26036315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical management of polymyalgia rheumatica.
    Gonzalez-Gay MA; Agudo M; Martinez-Dubois C; Pompei O; Blanco R
    Expert Opin Pharmacother; 2010 May; 11(7):1077-87. PubMed ID: 20367535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A disease activity score for polymyalgia rheumatica.
    Leeb BF; Bird HA
    Ann Rheum Dis; 2004 Oct; 63(10):1279-83. PubMed ID: 15361387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study.
    Ferraccioli G; Salaffi F; De Vita S; Casatta L; Bartoli E
    J Rheumatol; 1996 Apr; 23(4):624-8. PubMed ID: 8730115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey.
    Dasgupta B; Salvarani C; Schirmer M; Crowson CS; Maradit-Kremers H; Hutchings A; Matteson EL;
    J Rheumatol; 2008 Feb; 35(2):270-7. PubMed ID: 18050370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dutch College of General Practitioner's practice guideline on polymyalgia rheumatica and temporal arteritis].
    Eizenga WH; Hakvoort L; Dubbeld P; Geijer RM; Goudswaard AN;
    Ned Tijdschr Geneeskd; 2010; 154():A1919. PubMed ID: 20482924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).
    Leeb BF; Bird HA; Nesher G; Andel I; Hueber W; Logar D; Montecucco CM; Rovensky J; Sautner J; Sonnenblick M
    Ann Rheum Dis; 2003 Dec; 62(12):1189-94. PubMed ID: 14644857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymyalgia rheumatica with normal erythrocyte sedimentation rate: clinical aspects.
    Martínez-Taboada VM; Blanco R; Rodríguez-Valverde V
    Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S34-7. PubMed ID: 10948758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Polymyalgia rheumatica and aortic involvement].
    De Lorenzi C; Dorighi U; Camellino D; Rosa GM; Secchi GL; Cimmino MA; Brunelli C
    G Ital Cardiol (Rome); 2014 May; 15(5):306-12. PubMed ID: 25002171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.
    Nothnagl T; Leeb BF
    Drugs Aging; 2006; 23(5):391-402. PubMed ID: 16823992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study.
    Catanoso MG; Macchioni P; Boiardi L; Pipitone N; Salvarani C
    Arthritis Rheum; 2007 Dec; 57(8):1514-9. PubMed ID: 18050171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polymyalgia rheumatica in daily routine practice].
    Talke M; Schmidt WA
    Z Rheumatol; 2014 Jun; 73(5):408-14. PubMed ID: 24924726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug therapies for polymyalgia rheumatica: a pharmacotherapeutic update.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Opin Pharmacother; 2018 Aug; 19(11):1235-1244. PubMed ID: 30040482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.